What is CCUS? Everything You Need To Know With Dr. Kelly Bolton
SpotifyOn this episode of HealthTree Podcast for MDS, we are joined by Dr. Kelly Bolton, physician-scientist from Washington University in St. Louis Missouri. Dr. Bolton gives us, essentially a crash course on CCUS. She covers questions like, "what is CCUS?", "who should treat CCUS?", "what treatment options exist for CCUS?" and "what does progression in CCUS look like?". She ends by talking to us about her exciting PIMM trial in CCUS and how she believes studying CCUS can potentially help prevent patients from progressing into MDS or AML.
Listen to the episode to hear her answers to these questions and many more!
Mary Arnett
Mary joined HealthTree as the HealthTree for MDS Program Manager in 2022. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for MDS patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.
Kelly Bolton, MD
Kelly Bolton is a physician-scientist at Washington University in St Louis. She is currently an assistant professor in the Section of Stem Cell Biology Division, Division of Oncology. Her research group focuses on clonal hematopoiesis and inherited predisposition to cancer. Originally from Los Angeles, she completed her undergraduate studies at Cornell University. She completed medical school at the UCLA School of Medicine and a PhD in Genetic Epidemiology through Cambridge University. She went on to complete her residency in internal medicine and Cornell University and a fellowship in medical oncology at MSKCC. She receives grant support from the National Cancer Institute, the EvansMDS foundation and the Damon Runyon Cancer Research Foundation.
